Annual ROE
277.07%
+12.78%+4.84%
December 31, 2023
Summary
- As of February 7, 2025, PHAT annual return on equity is 277.07%, with the most recent change of +12.78% (+4.84%) on December 31, 2023.
- During the last 3 years, PHAT annual ROE has risen by +343.51% (+517.02%).
- PHAT annual ROE is now at all-time high.
Performance
PHAT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
211.43%
-39.90%-15.88%
September 30, 2024
Summary
- As of February 7, 2025, PHAT quarterly return on equity is 211.43%, with the most recent change of -39.90% (-15.88%) on September 30, 2024.
- Over the past year, PHAT quarterly ROE has dropped by -39.90% (-15.88%).
- PHAT quarterly ROE is now -97.54% below its all-time high of 8608.63%, reached on December 31, 2019.
Performance
PHAT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PHAT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.8% | -15.9% |
| 3 y3 years | +517.0% | -81.2% |
| 5 y5 years | +176.6% | -81.2% |
PHAT ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +238.9% | -81.2% | +122.7% |
| 5 y | 5-year | at high | +238.9% | -97.5% | +122.7% |
| alltime | all time | at high | +238.9% | -97.5% | +122.7% |
Phathom Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 211.43%(-15.9%) |
| Jun 2024 | - | 251.33%(-43.6%) |
| Mar 2024 | - | 445.51%(-9.9%) |
| Dec 2023 | 277.07%(+4.8%) | 494.32%(+15.3%) |
| Sep 2023 | - | 428.79%(+0.8%) |
| Jun 2023 | - | 425.51%(+8.3%) |
| Mar 2023 | - | 392.82%(-65.1%) |
| Dec 2022 | 264.29%(-232.5%) | 1126.59%(-221.1%) |
| Sep 2022 | - | -930.09%(+192.9%) |
| Jun 2022 | - | -317.55%(+83.4%) |
| Mar 2022 | - | -173.17%(+42.0%) |
| Dec 2021 | -199.41% | -121.91%(+11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -108.90%(+10.6%) |
| Jun 2021 | - | -98.42%(+20.4%) |
| Mar 2021 | - | -81.75%(+18.4%) |
| Dec 2020 | -66.44%(-40.6%) | -69.04%(-22.2%) |
| Sep 2020 | - | -88.73%(-49.4%) |
| Jun 2020 | - | -175.50%(-68.0%) |
| Mar 2020 | - | -548.58%(-106.4%) |
| Dec 2019 | -111.92%(-211.7%) | 8608.63%(+4235.5%) |
| Sep 2019 | - | 198.56%(-5.3%) |
| Jun 2019 | - | 209.61%(+33.1%) |
| Mar 2019 | - | 157.47%(+161.6%) |
| Dec 2018 | 100.16% | 60.19% |
FAQ
- What is Phathom Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals annual ROE year-on-year change?
- What is Phathom Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals quarterly ROE year-on-year change?
What is Phathom Pharmaceuticals annual return on equity?
The current annual ROE of PHAT is 277.07%
What is the all time high annual ROE for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high annual return on equity is 277.07%
What is Phathom Pharmaceuticals annual ROE year-on-year change?
Over the past year, PHAT annual return on equity has changed by +12.78% (+4.84%)
What is Phathom Pharmaceuticals quarterly return on equity?
The current quarterly ROE of PHAT is 211.43%
What is the all time high quarterly ROE for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high quarterly return on equity is 8608.63%
What is Phathom Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, PHAT quarterly return on equity has changed by -39.90% (-15.88%)